RGD Reference Report - The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

The many faces of alpha-synuclein: from structure and toxicity to therapeutic target.

Authors: Lashuel, HA  Overk, CR  Oueslati, A  Masliah, E 
Citation: Lashuel HA, etal., Nat Rev Neurosci. 2013 Jan;14(1):38-48. doi: 10.1038/nrn3406.
RGD ID: 10450770
Pubmed: PMID:23254192   (View Abstract at PubMed)
PMCID: PMC4295774   (View Article at PubMed Central)
DOI: DOI:10.1038/nrn3406   (Journal Full-text)

Disorders characterized by alpha-synuclein (alpha-syn) accumulation, Lewy body formation and parkinsonism (and in some cases dementia) are collectively known as Lewy body diseases. The molecular mechanism (or mechanisms) through which alpha-syn abnormally accumulates and contributes to neurodegeneration in these disorders remains unknown. Here, we provide an overview of current knowledge and prevailing hypotheses regarding the conformational, oligomerization and aggregation states of alpha-syn and their role in regulating alpha-syn function in health and disease. Understanding the nature of the various alpha-syn structures, how they are formed and their relative contributions to alpha-syn-mediated toxicity may inform future studies aiming to develop therapeutic prevention and intervention.


Additional Information